Capitol Health Limited zooms up with more radiology clinics

Capitol Health Limited (ASX: CAJ) is a medical diagnostic imaging company, which saw its stock price move up by 2.2% on June 27, 2018 (before market close) as the group has snapped up more radiology clinics. Capitol is under the acquisition of 9 independent clinics from 4 different vendors in WA. These acquisitions provide Capitol with a strategic platform for geographic expansion into the Perth and Melbourne market. It also expands Capitol’s Victorian network into the Mornington Peninsula region.

The clinic service offerings include sub specialty intervention and pain management, Cardiac CT, and general radiology and will bring well respected doctors into the Capitol group. Aggregate acquisition consideration is $17.0 million upfront on a cash and debt free basis and up to an additional $3.3 million payable under earn-out to the vendors over the first year of ownership (based on performance).

The new clinics are expected to contribute $16.5 million in revenue and $3.1 million in EBITDA on an annual basis (based on FY19 forecast). This represents an EBITDA multiple of 5.5 rising to 6.5 if all earn-out conditions are met. The transactions are expected to complete early in Q1FY19 (subject to satisfaction of standard conditions) and contribute strongly to the full year FY19 result.

These acquisitions are Capitol’s entry into the attractive Perth market. The initial 6 clinics will provide a critical mass to grow the business through additional capital investment, targeted recruitment and growth in the doctor group, and further acquisitions with several smaller bolt on opportunities in the pipeline. Whilst acquired from different vendors, Capitol expects to derive network benefits from the clinics as well as to strengthen key areas of sub specialty and further improve Capitol’s clinical standing.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s